Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Neuroendocrine Tumors 13Paraganglioma 5Carcinoid Tumor 5Pheochromocytoma 4Neuroblastoma 4von Hippel-Lindau Disease 3Multiple Endocrine Neoplasia Type 1 2Medulloblastoma 2Gastro-enteropancreatic neuroendocrine tumor 2Carcinoma, Neuroendocrine 2Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Somatostatinoma 1Parathyroid Neoplasms 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Multiple Endocrine Neoplasia 1Metastatic Neuroendocrine Prostate Cancer 1Meningioma 1Kidney Neoplasms 1Hypoglycemia 1Hypertension 1Hyperparathyroidism 1Hypercalcemia 1Head and Neck Neoplasms 1Adenoma, Islet Cell 1Adenocarcinoma, Follicular 1

Interventions

Trastuzumab 2Nivolumab 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1tipifarnib 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fluorodopa F 18 1fluorocholine 1entinostat 1Specimen Handling 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Immunotherapy 1Gefitinib 1Drug Therapy 1Dacarbazine 1CTLA-4 Antigen 1Bortezomib 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Parathyroid Neoplasms × gallium Ga 68 dotatate × Endocrine × Clear all
NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
1,553 enrolled 8 charts
EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡